These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2956236)

  • 41. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy.
    Schwimmbeck PL; Badorff C; Rohn G; Schulze K; Schultheiss HP
    Int J Cardiol; 1996 May; 54(2):117-25. PubMed ID: 8803675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In situ analysis with monoclonal antibodies of lymphocyte subsets in myocardial biopsies from patients with dilated cardiomyopathy and idiopathic (viral) myocarditis.
    Deguchi H; Hayashi T; Kotaka M; Nakayama Y; Kitaura Y; Kawamura K
    Jpn Circ J; 1987 Dec; 51(12):1365-72. PubMed ID: 3443989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.
    Maisch B; Deeg P; Liebau G; Kochsiek K
    Am J Cardiol; 1983 Nov; 52(8):1072-8. PubMed ID: 6356861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
    Caforio AL; Mahon NJ; Mckenna WJ
    Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Secondary immunopathogenesis in myocarditis, diseases of the heart muscles and infarct-associated arrhythmia in childhood and adulthood].
    Maisch B; Schwab D; Sandhage K; Schmaltz AA; Wimmer M
    Wien Klin Wochenschr; 1989 Jan; 101(1):31-9. PubMed ID: 2643844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.
    Kuethe F; Braun RK; Foerster M; Schlenker Y; Sigusch HH; Kroegel C; Figulla HR
    J Clin Immunol; 2006 Jan; 26(1):33-9. PubMed ID: 16418801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocarditis and dilated cardiomyopathy: possible connections and treatments.
    Castellano G; Affuso F; Di Conza P; Fazio S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pathogenesis of dilated cardiomyopathy.
    Olsen EG
    Postgrad Med J; 1992; 68 Suppl 1():S7-10. PubMed ID: 1409220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunological background of patients with dilated cardiomyopathy and myocarditis: clinical and experimental studies].
    Kishimoto C; Matsumori A; Tomioka N; Sakurai T; Kawai C
    J Cardiogr Suppl; 1986; (9):19-25. PubMed ID: 3020133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.
    Maekawa Y; Ouzounian M; Opavsky MA; Liu PP
    Circulation; 2007 Jan; 115(1):5-8. PubMed ID: 17200452
    [No Abstract]   [Full Text] [Related]  

  • 53. Humoral immunity and lymphocyte subpopulations in patients with dilated cardiomyopathy.
    Franceschini R; Messina V; Petillo A; Corazza M; Bottaro L; Gianrossi R
    Int J Cardiol; 1985 Jun; 8(2):113-23. PubMed ID: 3874172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of immune-mediated myocyte injury.
    Barry WH
    Circulation; 1994 May; 89(5):2421-32. PubMed ID: 8181167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of MHC-I and MHC-II antigens in endomyocardial biopsies from patients with viral myocarditis and cardiomyopathy.
    Li W; Yu S; Zhao H
    Chin Med J (Engl); 1995 Nov; 108(11):809-11. PubMed ID: 8585971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy.
    Maisch B
    Basic Res Cardiol; 1986; 81 Suppl 1():217-41. PubMed ID: 2947566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-mediated immune cardiocyte injury in viral myocarditis of mice and patients.
    Deguchi H; Kitaura Y; Hayashi T; Kotaka M; Kawamura K
    Jpn Circ J; 1989 Jan; 53(1):61-77. PubMed ID: 2541265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunophenotypic and functional characterization of peripheral blood mononuclear cell populations in patients with dilated cardiomyopathy.
    Grzelak I; Lukomska B; Sadowska-Szablisty D; Olszewski WL; Dabrowski M; Ruzyłło W
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):33-40. PubMed ID: 1839493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocarditis--cardiomyopathy. Consensus Report of the German Association for Internal Medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994.
    Strauer BE; Kandolf R; Mall G; Maisch B; Mertens T; Schwartzkopff B; Schultheiss HP
    Acta Cardiol; 1996; 51(4):347-71. PubMed ID: 8888893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Phenotype analysis of mononuclear cells from endomyocardial biopsy specimens in patients with viral myocarditis and dilated cardiomyopathy].
    Li W
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):364-6, 390. PubMed ID: 1307978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.